- Home
- SSII vs NVCR Comparison
SSII vs NVCR Comparison
Compare SSII & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSII
- NVCR
- Stock Information
- Founded
- SSII N/A
- NVCR 2000
- Country
- SSII India
- NVCR Switzerland
- Employees
- SSII N/A
- NVCR N/A
- Industry
- SSII
- NVCR Medical/Dental Instruments
- Sector
- SSII
- NVCR Health Care
- Exchange
- SSII Nasdaq
- NVCR Nasdaq
- Market Cap
- SSII 1.9B
- NVCR 1.9B
- IPO Year
- SSII N/A
- NVCR 2015
- Fundamental
- Price
- SSII $6.33
- NVCR $19.11
- Analyst Decision
- SSII
- NVCR Buy
- Analyst Count
- SSII 0
- NVCR 6
- Target Price
- SSII N/A
- NVCR $32.83
- AVG Volume (30 Days)
- SSII 93.2K
- NVCR 941.3K
- Earning Date
- SSII 05-14-2025
- NVCR 07-24-2025
- Dividend Yield
- SSII N/A
- NVCR N/A
- EPS Growth
- SSII N/A
- NVCR N/A
- EPS
- SSII N/A
- NVCR N/A
- Revenue
- SSII $22,132,445.00
- NVCR $621,711,000.00
- Revenue This Year
- SSII N/A
- NVCR $5.56
- Revenue Next Year
- SSII N/A
- NVCR $9.15
- P/E Ratio
- SSII N/A
- NVCR N/A
- Revenue Growth
- SSII 176.60
- NVCR 18.27
- 52 Week Low
- SSII $0.32
- NVCR $14.17
- 52 Week High
- SSII $22.42
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- SSII N/A
- NVCR 58.46
- Support Level
- SSII N/A
- NVCR $18.66
- Resistance Level
- SSII N/A
- NVCR $20.06
- Average True Range (ATR)
- SSII 0.00
- NVCR 0.86
- MACD
- SSII 0.00
- NVCR 0.19
- Stochastic Oscillator
- SSII 0.00
- NVCR 71.98
About SSII SS Innovations International Inc. Common Stock
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.